Report cover image

Global Human Growth Hormone Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 198 Pages
SKU # APRC20283984

Description

Summary

According to APO Research, The global Human Growth Hormone market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Human Growth Hormone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Growth Hormone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Human Growth Hormone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Growth Hormone is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human Growth Hormone include F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen, LG Life Sciences, Novo Nordisk, Sandoz International, Anhui Anke Biotechnology, Pfizer and GeneScience Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Human Growth Hormone, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Human Growth Hormone, also provides the revenue of main regions and countries. Of the upcoming market potential for Human Growth Hormone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Growth Hormone revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Human Growth Hormone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Human Growth Hormone revenue, projected growth trends, production technology, application and end-user industry.

Human Growth Hormone Segment by Company

F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Novo Nordisk
Sandoz International
Anhui Anke Biotechnology
Pfizer
GeneScience Pharmaceuticals
Eli Lilly
Merck Serono
Human Growth Hormone Segment by Type

Powder
Solvent
Human Growth Hormone Segment by Application

Small for Gestational Age
Turner Syndrome
Growth Hormone Deficiency (GHD)
Prader Willi Syndrome
Chronic Renal Insufficiency
SHOX Deficiency
Others
Human Growth Hormone Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Human Growth Hormone in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Human Growth Hormone company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Growth Hormone revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Human Growth Hormone Market by Type
1.2.1 Global Human Growth Hormone Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Powder
1.2.3 Solvent
1.3 Human Growth Hormone Market by Application
1.3.1 Global Human Growth Hormone Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Small for Gestational Age
1.3.3 Turner Syndrome
1.3.4 Growth Hormone Deficiency (GHD)
1.3.5 Prader Willi Syndrome
1.3.6 Chronic Renal Insufficiency
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Human Growth Hormone Market Dynamics
2.1 Human Growth Hormone Industry Trends
2.2 Human Growth Hormone Industry Drivers
2.3 Human Growth Hormone Industry Opportunities and Challenges
2.4 Human Growth Hormone Industry Restraints
3 Global Growth Perspective
3.1 Global Human Growth Hormone Market Perspective (2020-2031)
3.2 Global Human Growth Hormone Growth Trends by Region
3.2.1 Global Human Growth Hormone Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Human Growth Hormone Market Size by Region (2020-2025)
3.2.3 Global Human Growth Hormone Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Human Growth Hormone Revenue by Players
4.1.1 Global Human Growth Hormone Revenue by Players (2020-2025)
4.1.2 Global Human Growth Hormone Revenue Market Share by Players (2020-2025)
4.1.3 Global Human Growth Hormone Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Human Growth Hormone Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Human Growth Hormone Key Players Headquarters & Area Served
4.4 Global Human Growth Hormone Players, Product Type & Application
4.5 Global Human Growth Hormone Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Human Growth Hormone Market CR5 and HHI
4.6.3 2024 Human Growth Hormone Tier 1, Tier 2, and Tier 3
5 Human Growth Hormone Market Size by Type
5.1 Global Human Growth Hormone Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Human Growth Hormone Revenue by Type (2020-2031)
5.3 Global Human Growth Hormone Revenue Market Share by Type (2020-2031)
6 Human Growth Hormone Market Size by Application
6.1 Global Human Growth Hormone Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Human Growth Hormone Revenue by Application (2020-2031)
6.3 Global Human Growth Hormone Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Comapny Information
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.1.4 F. Hoffmann-La Roche Human Growth Hormone Product Portfolio
7.1.5 F. Hoffmann-La Roche Recent Developments
7.2 Ferring Pharmaceuticals
7.2.1 Ferring Pharmaceuticals Comapny Information
7.2.2 Ferring Pharmaceuticals Business Overview
7.2.3 Ferring Pharmaceuticals Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.2.4 Ferring Pharmaceuticals Human Growth Hormone Product Portfolio
7.2.5 Ferring Pharmaceuticals Recent Developments
7.3 Ipsen
7.3.1 Ipsen Comapny Information
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.3.4 Ipsen Human Growth Hormone Product Portfolio
7.3.5 Ipsen Recent Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Comapny Information
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.4.4 LG Life Sciences Human Growth Hormone Product Portfolio
7.4.5 LG Life Sciences Recent Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Comapny Information
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.5.4 Novo Nordisk Human Growth Hormone Product Portfolio
7.5.5 Novo Nordisk Recent Developments
7.6 Sandoz International
7.6.1 Sandoz International Comapny Information
7.6.2 Sandoz International Business Overview
7.6.3 Sandoz International Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.6.4 Sandoz International Human Growth Hormone Product Portfolio
7.6.5 Sandoz International Recent Developments
7.7 Anhui Anke Biotechnology
7.7.1 Anhui Anke Biotechnology Comapny Information
7.7.2 Anhui Anke Biotechnology Business Overview
7.7.3 Anhui Anke Biotechnology Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.7.4 Anhui Anke Biotechnology Human Growth Hormone Product Portfolio
7.7.5 Anhui Anke Biotechnology Recent Developments
7.8 Pfizer
7.8.1 Pfizer Comapny Information
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.8.4 Pfizer Human Growth Hormone Product Portfolio
7.8.5 Pfizer Recent Developments
7.9 GeneScience Pharmaceuticals
7.9.1 GeneScience Pharmaceuticals Comapny Information
7.9.2 GeneScience Pharmaceuticals Business Overview
7.9.3 GeneScience Pharmaceuticals Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.9.4 GeneScience Pharmaceuticals Human Growth Hormone Product Portfolio
7.9.5 GeneScience Pharmaceuticals Recent Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Comapny Information
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.10.4 Eli Lilly Human Growth Hormone Product Portfolio
7.10.5 Eli Lilly Recent Developments
7.11 Merck Serono
7.11.1 Merck Serono Comapny Information
7.11.2 Merck Serono Business Overview
7.11.3 Merck Serono Human Growth Hormone Revenue and Gross Margin (2020-2025)
7.11.4 Merck Serono Human Growth Hormone Product Portfolio
7.11.5 Merck Serono Recent Developments
8 North America
8.1 North America Human Growth Hormone Revenue (2020-2031)
8.2 North America Human Growth Hormone Revenue by Type (2020-2031)
8.2.1 North America Human Growth Hormone Revenue by Type (2020-2025)
8.2.2 North America Human Growth Hormone Revenue by Type (2026-2031)
8.3 North America Human Growth Hormone Revenue Share by Type (2020-2031)
8.4 North America Human Growth Hormone Revenue by Application (2020-2031)
8.4.1 North America Human Growth Hormone Revenue by Application (2020-2025)
8.4.2 North America Human Growth Hormone Revenue by Application (2026-2031)
8.5 North America Human Growth Hormone Revenue Share by Application (2020-2031)
8.6 North America Human Growth Hormone Revenue by Country
8.6.1 North America Human Growth Hormone Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Human Growth Hormone Revenue by Country (2020-2025)
8.6.3 North America Human Growth Hormone Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Human Growth Hormone Revenue (2020-2031)
9.2 Europe Human Growth Hormone Revenue by Type (2020-2031)
9.2.1 Europe Human Growth Hormone Revenue by Type (2020-2025)
9.2.2 Europe Human Growth Hormone Revenue by Type (2026-2031)
9.3 Europe Human Growth Hormone Revenue Share by Type (2020-2031)
9.4 Europe Human Growth Hormone Revenue by Application (2020-2031)
9.4.1 Europe Human Growth Hormone Revenue by Application (2020-2025)
9.4.2 Europe Human Growth Hormone Revenue by Application (2026-2031)
9.5 Europe Human Growth Hormone Revenue Share by Application (2020-2031)
9.6 Europe Human Growth Hormone Revenue by Country
9.6.1 Europe Human Growth Hormone Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Human Growth Hormone Revenue by Country (2020-2025)
9.6.3 Europe Human Growth Hormone Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Human Growth Hormone Revenue (2020-2031)
10.2 China Human Growth Hormone Revenue by Type (2020-2031)
10.2.1 China Human Growth Hormone Revenue by Type (2020-2025)
10.2.2 China Human Growth Hormone Revenue by Type (2026-2031)
10.3 China Human Growth Hormone Revenue Share by Type (2020-2031)
10.4 China Human Growth Hormone Revenue by Application (2020-2031)
10.4.1 China Human Growth Hormone Revenue by Application (2020-2025)
10.4.2 China Human Growth Hormone Revenue by Application (2026-2031)
10.5 China Human Growth Hormone Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Human Growth Hormone Revenue (2020-2031)
11.2 Asia Human Growth Hormone Revenue by Type (2020-2031)
11.2.1 Asia Human Growth Hormone Revenue by Type (2020-2025)
11.2.2 Asia Human Growth Hormone Revenue by Type (2026-2031)
11.3 Asia Human Growth Hormone Revenue Share by Type (2020-2031)
11.4 Asia Human Growth Hormone Revenue by Application (2020-2031)
11.4.1 Asia Human Growth Hormone Revenue by Application (2020-2025)
11.4.2 Asia Human Growth Hormone Revenue by Application (2026-2031)
11.5 Asia Human Growth Hormone Revenue Share by Application (2020-2031)
11.6 Asia Human Growth Hormone Revenue by Country
11.6.1 Asia Human Growth Hormone Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Human Growth Hormone Revenue by Country (2020-2025)
11.6.3 Asia Human Growth Hormone Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Human Growth Hormone Revenue (2020-2031)
12.2 SAMEA Human Growth Hormone Revenue by Type (2020-2031)
12.2.1 SAMEA Human Growth Hormone Revenue by Type (2020-2025)
12.2.2 SAMEA Human Growth Hormone Revenue by Type (2026-2031)
12.3 SAMEA Human Growth Hormone Revenue Share by Type (2020-2031)
12.4 SAMEA Human Growth Hormone Revenue by Application (2020-2031)
12.4.1 SAMEA Human Growth Hormone Revenue by Application (2020-2025)
12.4.2 SAMEA Human Growth Hormone Revenue by Application (2026-2031)
12.5 SAMEA Human Growth Hormone Revenue Share by Application (2020-2031)
12.6 SAMEA Human Growth Hormone Revenue by Country
12.6.1 SAMEA Human Growth Hormone Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Human Growth Hormone Revenue by Country (2020-2025)
12.6.3 SAMEA Human Growth Hormone Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.